SINTX TECHNOLOGIES (SINT)
(Real Time Quote from BATS)
$2.69 USD
0.00 (0.00%)
Updated Aug 7, 2025 12:46 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SINT 2.69 0.00(0.00%)
Will SINT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SINT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SINT
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates
SINT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SINT
SINTX Technologies (SINT) Publishes Key Biomaterial Study
Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates
SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates | SINT ...
SINTX Technologies (SINT) Submits FDA Application for New Orthopedic Implants | SINT Stock News
SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices | ...